Abiopharma

🔍 Musunuri Shankar (Director)

Company: Ocugen, Inc. (OCGN)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 3,123,201 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,955,924.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: H | nature_of_ownership: By: KVM Holdings, LLC | shares_owned_after: 1,145,299.00 | Footnotes: F2
• Acquired 3,123,201 shares of Option (Right to Buy) at $1.38 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 3,123,201.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Reflects a grant of performance stock units ("PSUs"). Each PSU represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain performance goals, subject to continued service with the Issuer on the applicable vesting dates.
• F2: The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
• F3: The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.